Muscle's role in regulating nerve terminal properties

肌肉在调节神经末梢特性中的作用

基本信息

  • 批准号:
    6645013
  • 负责人:
  • 金额:
    $ 5.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-07-01 至 2003-06-30
  • 项目状态:
    已结题

项目摘要

The broad objective of this application is to understand how changes in muscle induced by changes in activity are important in promoting reinnervation and maintaining established synapses; and to attempt to mimic activity-induced changes with gene therapy. Although it is known that nerve terminal and muscle interact to modulate structure and function of the neuromuscular junction, the role of muscle in this interaction remains poorly understood. The advent of new animal models and gene therapy technology have made possible new experiments to examine the role of muscle in promoting and maintaining innervation. Two specific aims are proposed: (1) to determine whether changes in muscle during inactivity, denervation or reinnervation are essential for maintenance or reestablishment of normal structure and function of the neuromuscular junction. Two new animal models of disease will be used in this aims to increase muscle activity (the Clc-1 mouse in which denervated muscle remains active) or decrease muscle activity (a model for acute quadriplegic myopathy in which denervated muscle treated with corticosteroids become inexcitable). (2) to determine whether introduction of transcription factors into muscle to directly induce or prevent denervation-like changes in muscle can alter neuromuscular junction structure and function. In this aim replication deficient adenoviruses containing either myogenin or factors that block activity of myogenin will be used to induce or prevent denervation-like changes of gene expression in muscle. The effect on structure and function of mature and reinnervated neuromuscular junctions will be determined. The proposed experiments will help determine ways in which to manipulate muscle to improve junction of the neuromuscular junction in diseases of motor neuron, nerve, neuromuscular junction and muscle.
本申请的广泛目标是了解由活动变化诱导的肌肉变化如何在促进神经再支配和维持已建立的突触中是重要的;并尝试用基因疗法模拟活动诱导的变化。虽然已知神经末梢和肌肉相互作用以调节神经肌肉接头的结构和功能,但肌肉在这种相互作用中的作用仍然知之甚少。新的动物模型和基因治疗技术的出现,使得研究肌肉在促进和维持神经支配中的作用的新实验成为可能。提出了两个具体目标:(1)确定肌肉在不活动、去神经支配或再神经支配期间的变化是否对维持或重建神经肌肉接头的正常结构和功能至关重要。两种新的疾病动物模型将用于此目的,以增加肌肉活动(Clc-1小鼠,其中失神经肌肉保持活动)或减少肌肉活动(急性四肢瘫痪性肌病模型,其中用皮质类固醇治疗的失神经肌肉变得不可兴奋)。(2)确定将转录因子引入肌肉中以直接诱导或防止肌肉中的去神经样变化是否可以改变神经肌肉接头结构和功能。在这个目标中,含有肌细胞生成素或阻断肌细胞生成素活性的因子的复制缺陷型腺病毒将用于诱导或预防肌肉中基因表达的去神经样变化。将确定对成熟和重新神经支配的神经肌肉接头的结构和功能的影响。拟议的实验将有助于确定如何操纵肌肉,以改善运动神经元,神经,神经肌肉接头和肌肉疾病的神经肌肉接头的连接。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARK M RICH其他文献

MARK M RICH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARK M RICH', 18)}}的其他基金

Novel Approaches to Therapy of Muscle Ion Channelopathies
治疗肌肉离子通道病的新方法
  • 批准号:
    10398427
  • 财政年份:
    2019
  • 资助金额:
    $ 5.57万
  • 项目类别:
Novel Approaches to Therapy of Muscle Ion Channelopathies
治疗肌肉离子通道病的新方法
  • 批准号:
    10400916
  • 财政年份:
    2019
  • 资助金额:
    $ 5.57万
  • 项目类别:
Novel Approaches to Therapy of Muscle Ion Channelopathies
治疗肌肉离子通道病的新方法
  • 批准号:
    9895630
  • 财政年份:
    2019
  • 资助金额:
    $ 5.57万
  • 项目类别:
Development of novel therapy for hypokalemic periodic paralysis
低钾性周期性麻痹新疗法的开发
  • 批准号:
    9926525
  • 财政年份:
    2019
  • 资助金额:
    $ 5.57万
  • 项目类别:
Reduced Motoneuron Excitability in Sepsis
脓毒症时运动神经元兴奋性降低
  • 批准号:
    9309088
  • 财政年份:
    2014
  • 资助金额:
    $ 5.57万
  • 项目类别:
Reduced Motoneuron Excitability in Sepsis
脓毒症时运动神经元兴奋性降低
  • 批准号:
    8760655
  • 财政年份:
    2014
  • 资助金额:
    $ 5.57万
  • 项目类别:
Reduced Motoneuron Excitability in Sepsis
脓毒症时运动神经元兴奋性降低
  • 批准号:
    9100941
  • 财政年份:
    2014
  • 资助金额:
    $ 5.57万
  • 项目类别:
RETROGRADE TROPHIC SIGNALING THROUGH ACETYLCHOLINE RECEPTORS AT THE NEUROMUSCULA
通过神经肌肉乙酰胆碱受体的逆行营养信号传导
  • 批准号:
    8562569
  • 财政年份:
    2007
  • 资助金额:
    $ 5.57万
  • 项目类别:
RETROGRADE TROPHIC SIGNALING THROUGH ACETYLCHOLINE RECEPTORS AT THE NEUROMUSCULA
通过神经肌肉乙酰胆碱受体的逆行营养信号传导
  • 批准号:
    8816147
  • 财政年份:
    2007
  • 资助金额:
    $ 5.57万
  • 项目类别:
RETROGRADE TROPHIC SIGNALING THROUGH ACETYLCHOLINE RECEPTORS AT THE NEUROMUSCULA
通过神经肌肉乙酰胆碱受体的逆行营养信号传导
  • 批准号:
    8627654
  • 财政年份:
    2007
  • 资助金额:
    $ 5.57万
  • 项目类别:

相似海外基金

ICF: A novel dual-target gene therapy for safe and efficacious treatment of chronic non-infectious uveitis
ICF:一种安全有效治疗慢性非感染性葡萄膜炎的新型双靶点基因疗法
  • 批准号:
    MR/Z50385X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Research Grant
Next-generation automation and PAT implementation for QbD and enhanced approaches for cell and gene therapy
QbD 的下一代自动化和 PAT 实施以及细胞和基因治疗的增强方法
  • 批准号:
    10087446
  • 财政年份:
    2024
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Collaborative R&D
Longitudinal structural and cognitive functional imaging and outcome prediction in focal epilepsy treated with gene therapy and surgical resection.
基因治疗和手术切除治疗局灶性癫痫的纵向结构和认知功能成像及结果预测。
  • 批准号:
    MR/X031039/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Research Grant
Phase I/II clinical trial of autologous T cell gene therapy to treat X-linked lymphoproliferative disease (XLP)
自体T细胞基因疗法治疗X连锁淋巴增殖性疾病(XLP)的I/II期临床试验
  • 批准号:
    MR/Y019458/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Research Grant
GeneT: The Gene Therapy CoE at the Center of Portugal
GeneT:葡萄牙中心的基因治疗 CoE
  • 批准号:
    10090933
  • 财政年份:
    2024
  • 资助金额:
    $ 5.57万
  • 项目类别:
    EU-Funded
SBIR Phase I: Development of an Adjustable Gene Therapy Platform Technology
SBIR 第一阶段:可调节基因治疗平台技术的开发
  • 批准号:
    2240683
  • 财政年份:
    2023
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Standard Grant
Exploration novel effects of SHED-TK-derived exosomes on TK/GCV suicide gene therapy
探索SHED-TK衍生的外泌体对TK/GCV自杀基因治疗的新作用
  • 批准号:
    23K15643
  • 财政年份:
    2023
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Gene expression profiling of skin ulcers for short-acting in vivo gene therapy
皮肤溃疡的基因表达谱用于短效体内基因治疗
  • 批准号:
    23K19673
  • 财政年份:
    2023
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Activation of long non-coding RNA by a gene therapy CRISPR/Cas9 approach to prevent vein graft failure
通过基因治疗 CRISPR/Cas9 方法激活长非编码 RNA 以预防静脉移植失败
  • 批准号:
    EP/X024563/1
  • 财政年份:
    2023
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Research Grant
Developing a gene therapy product to treat pressure ulcers in lower-limb amputees
开发一种基因治疗产品来治疗下肢截肢者的压力性溃疡
  • 批准号:
    2888189
  • 财政年份:
    2023
  • 资助金额:
    $ 5.57万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了